tiprankstipranks
Allarity Therapeutics Secures Critical Nasdaq Hearing Opportunity
Company Announcements

Allarity Therapeutics Secures Critical Nasdaq Hearing Opportunity

Don't Miss Our Christmas Offers:

Allarity Therapeutics, Inc. (ALLR) has provided an announcement.

Allarity Therapeutics, Inc. has announced they have secured a hearing before a Nasdaq hearings panel following a notice received from The Nasdaq Stock Market LLC. This development is critical for stakeholders and potential investors as it could influence the company’s stock market presence and future financial direction.

See more insights into ALLR stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyAllarity reports progress in Phase 2 stenoparib trial
TheFlyAllarity reports Q3 EPS ($7.71)
TheFlyAllarity granted EPO for DRP companion diagnostic for stenoparib
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App